Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis CIRCULATION Lindner, S. M., Fordyce, C. B., Hellkamp, A. S., Lokhnygina, Y., Piccini, J. P., Breithardt, G., Mahaffey, K. W., Singer, D. E., Hacke, W., Halperin, J. L., Hankey, G. J., Berkowitz, S. D., Nessel, C. C., Becker, R. C., Fox, K. A., Patel, M. R., ROCKET AF Steering Comm 2017; 135 (10): 1001–3

View details for PubMedID 28264892